| Acne |
No |
| Active substance |
Gliclazide |
| Also known as |
Glyclazide |
| Aromatization |
No |
| Blood pressure |
No significant impact on blood pressure |
| Chemical name |
1-(3-azabicyclo[3.3.0]oct-3-yl)-3-(p-tolylsulfonyl)urea |
| Dosage (medical) |
Typically 40-120 mg per day, depending on patient response and formulation (immediate or extended release) |
| Dosage (sports) |
Not applicable |
| Effects |
Lowers blood glucose levels by stimulating insulin release from pancreatic beta cells |
| Formula |
C15H21N3O3S |
| Half-life |
10-12 hours |
| HBR |
No |
| Hepatotoxicity |
No |
| Lab Test |
Blood glucose monitoring, hemoglobin A1c |
| Main action |
Hypoglycemic agent |
| Side effects |
Hypoglycemia, gastrointestinal disturbances (e.g., nausea, indigestion), dizziness, headache |
| Storage conditions |
Store at room temperature away from moisture and heat |
| Substance class |
Sulfonylurea |
| Trade name |
Diamicron, among others |
| Use in sports |
Not typically used in sports |
| WAREHOUSE |
International Warehouse 2 |
| Water Retention |
No |
| Manufacturer |
Servier |
